[January 31, 2013] Uptrend Call Working As Alnylam Pharmaceuticals Stock Rises 24.2% (ALNY) Tweet Jan 31, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Alnylam Pharmaceuticals (NASDAQ:ALNY) on December 12th, 2012 at $18.85. In approximately 2 months, Alnylam Pharmaceuticals has returned 24.22% as of today's recent price of $23.41. In the past 52 weeks, Alnylam Pharmaceuticals share prices have been bracketed by a low of $9.51 and a high of $25.00 and are now at $23.41, 146% above that low price. The 200-day and 50-day moving averages have moved 1.35% higher and 2.74% higher over the past week, respectively. Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Alnylam Pharmaceuticals shares.Log in and add Alnylam Pharmaceuticals (ALNY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]